Viewing Study NCT04115761


Ignite Creation Date: 2025-12-24 @ 12:54 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT04115761
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2019-10-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Sponsor: Ever Supreme Bio Technology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module